FDA Drug Application (206353) for EVOTAZ by BRISTOL-MYERS SQUIBB

Back to FDA Applications sponsored by BRISTOL-MYERS SQUIBB

Application Number206353
Product Number001
FormTABLET;ORAL
DosageEQ 300MG BASE;150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEVOTAZ
Active IngredientATAZANAVIR SULFATE; COBICISTAT

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6
List of drugs with Active Ingredient COBICISTAT5


Back to FDA Applications sponsored by BRISTOL-MYERS SQUIBB